Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease

Bone Marrow Transplantation volume 52, pages 1180–1186 (2017)Cite this article

Subjects

Abstract

The significance of upper gastrointestinal tract (UGI) acute GVHD (aGVHD) compared with other grade II aGVHD is not clearly defined. We compared the outcomes of patients with grade II aGVHD with or without biopsy-proven UGI involvement in three groups: grade II aGVHD without UGI (n=178), grade II aGVHD with UGI and other sites (n=102) and isolated UGI aGVHD (n=32). The overall response (ORR) to steroids at day 28 differed among the three groups (76, 67 and 91%, respectively, P=0.01), but was only marginally different in direct comparison with those without or with UGI aGVHD (P=0.07) or with isolated UGI aGVHD (P=0.06). In multivariate analysis, as compared with grade II aGVHD patients without UGI involvement, those with UGI involvement and those with isolated UGI aGVHD had similar risks of chronic GVHD, relapse and non-relapse mortality and similar disease-free survival and overall survival. Our data suggest that patients with UGI aGVHD have similar outcomes as those without UGI involvement, supporting the view that UGI aGVHD should still be included as a grade II-defining event.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990; 76: 624–629.

    CAS  PubMed  Google Scholar 

  2. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  3. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  4. Nikiforow S, Hemmer M, Spellman SR, Alousi AM, Couriel DR, Pidala JA et al. Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value when present in isolation or in addition to grade I or other grade II-defining GvHD manifestations. Blood 2015; 126: 857.

    Google Scholar 

  5. MacMillan ML, DeFor TE, Weisdorf DJ . The best endpoint for acute GVHD treatment trials. Blood 2010; 115: 5412–5417.

    Article  CAS  PubMed  Google Scholar 

  6. Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J et al. Graft-versus-host disease treatment: predictors of survival. Biol Blood Marrow Transplant 2010; 16: 1693–1699.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hings IM, Filipovich AH, Miller WJ, Blazar BL, McGlave PB, Ramsay NK et al. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation 1993; 56: 577–580.

    Article  CAS  PubMed  Google Scholar 

  8. MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant 2015; 21: 761–767.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kaplan EL, Meier P . Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  10. Lin DY . Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901–910.

    Article  CAS  PubMed  Google Scholar 

  11. Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496–509.

    Article  Google Scholar 

  12. ASBMT. American Society for Blood and Marrow Transplantation RFI 2006. http://www.asbmt.org2006.

  13. Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation 1986; 42: 602–607.

    Article  CAS  PubMed  Google Scholar 

  14. Kruger GR, Berard CW, DeLellis RA, Graw RG Jr, Yankee RA, Leventhal BG et al. Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation. Am J Pathol 1971; 63: 179–202.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Sale GE, Shulman HM, McDonald GB, Thomas ED . Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291–299.

    Article  CAS  PubMed  Google Scholar 

  16. Snover DC, Weisdorf SA, Vercellotti GM, Rank B, Hutton S, McGlave P . A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 1985; 16: 387–392.

    Article  CAS  PubMed  Google Scholar 

  17. Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 1998; 66: 1319–1324.

    Article  CAS  PubMed  Google Scholar 

  18. Levine JE, Braun TM, Harris AC, Holler E, Taylor A, Miller H et al. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. Lancet Haematol 2015; 2: e21–e29.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Holtan SG, MacMillan ML . A risk-adapted approach to acute GVHD treatment: are we there yet? Bone Marrow Transplant 2016; 51: 172–175.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all patients, their families, nurses who took care of them and research nurses for their support and dedication in collecting these data.

Author information

Authors and Affiliations

  1. Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center,, Houston, TX, USA

    R S Mehta, Q Cao, S Holtan, M L MacMillan & D J Weisdorf

Authors
  1. R S Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Q Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Holtan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M L MacMillan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D J Weisdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R S Mehta.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehta, R., Cao, Q., Holtan, S. et al. Upper GI GVHD: similar outcomes to other grade II graft-versus-host disease. Bone Marrow Transplant 52, 1180–1186 (2017). https://doi.org/10.1038/bmt.2017.90

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2017.90

Search

Advanced search

Quick links